EMA approves Pfizer and Moderna Covid-19 booster shots

The European Medicines Agency recommends that immunocompromised people receive a third dose of one of the coronavirus vaccines, and states that a third Pfizer jab should be considered for all adults.

Photo: Dado Ruvic/Reuters/Ritzau Scanpix

People with a significantly compromised immune system should receive a third dose – also called a booster shot – of the Covid-19 vaccine developed by Pfizer/BioNTech or Moderna, the European Medicines Agency (EMA) states.

This should happen at least 28 days after the person has received their second jab.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs